ClinicaliQ Trial Snapshot
- Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation — Recruiting • Cardiology / Cardiovascular • NCT06951100.
- What is being tested: The study investigates the mechanisms of myocardial injury in rapid atrial fibrillation patients by measuring troponin levels (cardiac biomarker) and performing coronary imaging to determine whether myocardial damage results from demand ischaemia or underlying coronary artery disease.
- Patient eligibility overview: This observational study recruits patients presenting with rapid atrial fibrillation who require clinical assessment; participants undergo standard troponin testing and coronary imaging as part of routine clinical evaluation without randomisation to different treatment arms.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this observational study is to better understand the role of measuring troponin (a protein measured by a blood test) and coronary imaging in patients presenting with rapid atrial fibrillation (AF) The main questions this study aims to answer are: 1. Are patients with a fast, irregular heartbeat (rapid AF) and damage to the heart (myocardial injury) more likely than those without damage to the heart to have blocked heart arteries (obstructive coronary artery disease) 2. Are patients with a fast, irregular heartbeat (rapid AF) and damage to…
Eligibility Snapshot
- : 1. Age 18 years and over 2. Primary presentation with symptoms related to atrial fibrillation 3. Atrial fibrillation with a ventricular rate >100 bpm on a 12-lead electrocardiogram 4. Able to provide informed consent
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.